201 related articles for article (PubMed ID: 9407057)
1. Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1.
Rouillé Y; Kantengwa S; Irminger JC; Halban PA
J Biol Chem; 1997 Dec; 272(52):32810-6. PubMed ID: 9407057
[TBL] [Abstract][Full Text] [Related]
2. Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide.
Rouillé Y; Martin S; Steiner DF
J Biol Chem; 1995 Nov; 270(44):26488-96. PubMed ID: 7592866
[TBL] [Abstract][Full Text] [Related]
3. Proglucagon processing in an islet cell line: effects of PC1 overexpression and PC2 depletion.
Dhanvantari S; Brubaker PL
Endocrinology; 1998 Apr; 139(4):1630-7. PubMed ID: 9528943
[TBL] [Abstract][Full Text] [Related]
4. Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.
Rouillé Y; Westermark G; Martin SK; Steiner DF
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3242-6. PubMed ID: 8159732
[TBL] [Abstract][Full Text] [Related]
5. Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon.
Rouillé Y; Bianchi M; Irminger JC; Halban PA
FEBS Lett; 1997 Aug; 413(1):119-23. PubMed ID: 9287128
[TBL] [Abstract][Full Text] [Related]
6. Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagon.
Dey A; Lipkind GM; Rouillé Y; Norrbom C; Stein J; Zhang C; Carroll R; Steiner DF
Endocrinology; 2005 Feb; 146(2):713-27. PubMed ID: 15528303
[TBL] [Abstract][Full Text] [Related]
7. Role of prohormone convertases in the tissue-specific processing of proglucagon.
Dhanvantari S; Seidah NG; Brubaker PL
Mol Endocrinol; 1996 Apr; 10(4):342-55. PubMed ID: 8721980
[TBL] [Abstract][Full Text] [Related]
8. The role of prohormone convertases PC1 (PC3) and PC2 in the cell-specific processing of proglucagon.
Mineo I; Matsumura T; Shingu R; Namba M; Kuwajima M; Matsuzawa Y
Biochem Biophys Res Commun; 1995 Feb; 207(2):646-51. PubMed ID: 7864855
[TBL] [Abstract][Full Text] [Related]
9. Processing of mouse proglucagon by recombinant prohormone convertase 1 and immunopurified prohormone convertase 2 in vitro.
Rothenberg ME; Eilertson CD; Klein K; Zhou Y; Lindberg I; McDonald JK; Mackin RB; Noe BD
J Biol Chem; 1995 Apr; 270(17):10136-46. PubMed ID: 7730317
[TBL] [Abstract][Full Text] [Related]
10. Immunological detection of prohormone convertases in two different proglucagon processing cell lines.
Blache P; Le-Nguyen D; Boegner-Lemoine C; Cohen-Solal A; Bataille D; Kervran A
FEBS Lett; 1994 May; 344(1):65-8. PubMed ID: 8181567
[TBL] [Abstract][Full Text] [Related]
11. Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2.
Damholt AB; Buchan AM; Holst JJ; Kofod H
Endocrinology; 1999 Oct; 140(10):4800-8. PubMed ID: 10499540
[TBL] [Abstract][Full Text] [Related]
12. Proglucagon processing in islet and intestinal cell lines.
Tucker JD; Dhanvantari S; Brubaker PL
Regul Pept; 1996 Apr; 62(1):29-35. PubMed ID: 8738879
[TBL] [Abstract][Full Text] [Related]
13. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.
Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ
Endocrinology; 2004 Mar; 145(3):1349-55. PubMed ID: 14630721
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and PC1-mediated processing of human proglucagon, glicentin, and major proglucagon fragment.
Bonic A; Mackin RB
Protein Expr Purif; 2003 Mar; 28(1):15-24. PubMed ID: 12651102
[TBL] [Abstract][Full Text] [Related]
15. Altered proglucagon processing in an alpha-cell line derived from prohormone convertase 2 null mouse islets.
Webb GC; Dey A; Wang J; Stein J; Milewski M; Steiner DF
J Biol Chem; 2004 Jul; 279(30):31068-75. PubMed ID: 15143067
[TBL] [Abstract][Full Text] [Related]
16. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
17. Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
Perakakis N; Kalra B; Angelidi AM; Kumar A; Gavrieli A; Yannakoulia M; Mantzoros CS
Metabolism; 2022 Apr; 129():155157. PubMed ID: 35114286
[TBL] [Abstract][Full Text] [Related]
18. Regulatory roles of the P domain of the subtilisin-like prohormone convertases.
Zhou A; Martin S; Lipkind G; LaMendola J; Steiner DF
J Biol Chem; 1998 May; 273(18):11107-14. PubMed ID: 9556596
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
Perakakis N; Kokkinos A; Angelidi AM; Tsilingiris D; Gavrieli A; Yannakoulia M; Tentolouris N; Mantzoros CS
Clin Nutr; 2022 Sep; 41(9):1969-1976. PubMed ID: 35961260
[TBL] [Abstract][Full Text] [Related]
20. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.
Zhu X; Zhou A; Dey A; Norrbom C; Carroll R; Zhang C; Laurent V; Lindberg I; Ugleholdt R; Holst JJ; Steiner DF
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10293-8. PubMed ID: 12145326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
